According to the NCI Thesaurus13 definition, Gefitinib inhibits the catalytic activity of numerous tyrosine kinases, including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase-dependent tumor growth. The gene discussed is EGFR; the disease is neoplasm.